Stanford University School of Medicine Provides Update on Nu Skin Relationship
The Department of Dermatology in the Stanford School of Medicine has had a long-standing research-based relationship with Nu Skin Enterprises (NYSE: NUS). Researchers in the department currently have one on-going study funded by Nu Skin related to the identification of master regulators and epigenetic changes to human skin aging. This research project is funded from a $1.5 million commitment from Nu Skin and runs through 2014. Since 1999, the company has funded nearly $5.8 million dollars in research in the Department of Dermatology.
At the request of Dr. Stuart Kim, a letter was sent by Stanford to Nu Skin requesting Dr. Kim's name be removed from the company's marketing materials and websites as Dr. Kim is no longer involved with research funded by the company. The company complied with this request. The letter did not recognize, however, the existing research relationship between Nu Skin and Stanford. We regret any misunderstanding that may have occurred as a result.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.